Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
6h
Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs
The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...
13h
Palantir Stock Investors Need to Know This
Detailed price information for Palantir Technologies Inc Cl A (PLTR-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tapped for health secretary
Charged over Capitol riot
Trump meets with Milei
OH trans bathroom bill
Ben & Jerry's sues Unilever
Bohannan requests recount
To run Interior Department
World’s most polluting cities
Gender-affirming care ban
UFO reports spike
Leonid meteor shower
Moon volcanoes study
Bitcoin hacker sentenced
NYC gang war indictments
Rapper pleads not guilty
Alleged ISIS support charge
UK jets track RU aircraft
18 states sue SEC, Gensler
New Jersey forest fire arrest
Citigroup facing US probe
US finalizes $6.6B in funding
Sims replacing Sterling
CDC: OD deaths down
To host Oscars in 2025
Laken Riley murder trial
Bed rails recalled
Tiafoe fined $120,000
APEC Peru 2024
Opposition leader convicted
Laying off about 1K workers
US retail sales climb
Feedback